Publications by authors named "Joseph Wajdula"

Claim this Profile
V
Variability in Antinuclear Antibody Testing to Assess Patient Eligibility for Clinical Trials of Novel Treatments for Systemic Lupus Erythematosus.
David S Pisetsky, Dana Kathryn Thompson, Joseph Wajdula, Annette Diehl, Sudhakar Sridharan

Arthritis Rheumatol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial.
Daniel J Wallace, Vibeke Strand, Joan T Merrill, Serghei Popa, Alberto J Spindler, Joseph Wajdula

Ann Rheum Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study.
Walter P Maksymowych, Maxime Dougados, Désirée van der Heijde, Joachim Sieper, Jürgen Braun, Joseph Wajdula

Ann Rheum Dis· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis.
Tamas Constantin, Ivan Foeldvari, Jelena Vojinovic, Gerd Horneff, Ruben Burgos-Vargas, Joseph Wajdula

J Rheumatol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials.
Tsutomu Takeuchi, Nobuyuki Miyasaka, Shinichi Kawai, Naonobu Sugiyama, Hirotoshi Yuasa, Joseph Wajdula

Mod Rheumatol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial.
Maxime Dougados, Désirée van der Heijde, Joachim Sieper, Jürgen Braun, Walter P Maksymowych, Joseph Wajdula

Arthritis Rheumatol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.
Gerd Horneff, Ruben Burgos-Vargas, Tamas Constantin, Ivan Foeldvari, Jelena Vojinovic, Joseph Wajdula

Ann Rheum Dis· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3 randomized, double-blind, multicenter comparative study evaluating the effect of etanercept versus methotrexate on radiographic outcomes, disease activity, and safety in Japanese subjects with active rheumatoid arthritis.
Tsutomu Takeuchi, Nobuyuki Miyasaka, Chuanbo Zang, Daniel Alvarez, Tracey Fletcher, Joseph Wajdula

Mod Rheumatol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan.
Masaaki Mori, Syuji Takei, Tomoyuki Imagawa, Hiroyuki Imanaka, Yasuhito Nerome, Joseph S Wajdula

Mod Rheumatol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials.
Masaaki Mori, Syuji Takei, Tomoyuki Imagawa, Hiroyuki Imanaka, Yasuhito Nerome, Joseph S Wajdula

Mod Rheumatol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial safety and mortality analyses in patients receiving etanercept across approved indications.
Alice B Gottlieb, Kenneth Gordon, Edward H Giannini, Philip Mease, Juan Li, Joseph Wajdula

J Drugs Dermatol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis.
Kristian Reich, Siegfried Segaert, Peter Van de Kerkhof, Cis Durian, Marie Pierre Boussuge, Joseph Wajdula

Dermatology· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etanercept in the longterm treatment of patients with ankylosing spondylitis.
Ben Dijkmans, Paul Emery, Markku Hakala, Marjatta Leirisalo-Repo, Emilio Martin Mola, Joseph Wajdula

J Rheumatol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.
Désirée van der Heijde, Lars Klareskog, Vicente Rodriguez-Valverde, Catalin Codreanu, Horatiu Bolosiu, Joseph Wajdula

Arthritis Rheum· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Honghui Zhou, Philip R Mayer, Joseph Wajdula, Saeed Fatenejad

J Clin Pharmacol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
Lars Klareskog, Désirée van der Heijde, Julien P de Jager, Andrew Gough, Joachim Kalden, Joseph Wajdula

Lancet· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis